- Home
- GSBC vs SIGA Comparison
GSBC vs SIGA Comparison
Compare GSBC & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSBC
- SIGA
- Stock Information
- Founded
- GSBC 1923
- SIGA 1995
- Country
- GSBC United States
- SIGA United States
- Employees
- GSBC N/A
- SIGA N/A
- Industry
- GSBC Major Banks
- SIGA Biotechnology: Pharmaceutical Preparations
- Sector
- GSBC Finance
- SIGA Health Care
- Exchange
- GSBC Nasdaq
- SIGA Nasdaq
- Market Cap
- GSBC 654.8M
- SIGA 551.0M
- IPO Year
- GSBC N/A
- SIGA 1997
- Fundamental
- Price
- GSBC $63.66
- SIGA $7.63
- Analyst Decision
- GSBC Hold
- SIGA
- Analyst Count
- GSBC 2
- SIGA 0
- Target Price
- GSBC $60.00
- SIGA N/A
- AVG Volume (30 Days)
- GSBC 23.8K
- SIGA 422.0K
- Earning Date
- GSBC 10-16-2024
- SIGA 11-07-2024
- Dividend Yield
- GSBC 2.48%
- SIGA 7.83%
- EPS Growth
- GSBC N/A
- SIGA 197.35
- EPS
- GSBC 5.07
- SIGA 1.17
- Revenue
- GSBC $214,729,000.00
- SIGA $172,956,776.00
- Revenue This Year
- GSBC N/A
- SIGA $16.98
- Revenue Next Year
- GSBC $4.21
- SIGA $16.49
- P/E Ratio
- GSBC $12.72
- SIGA $6.56
- Revenue Growth
- GSBC N/A
- SIGA 76.90
- 52 Week Low
- GSBC $48.19
- SIGA $4.26
- 52 Week High
- GSBC $68.02
- SIGA $12.83
- Technical
- Relative Strength Index (RSI)
- GSBC 62.63
- SIGA 59.91
- Support Level
- GSBC $56.31
- SIGA $6.80
- Resistance Level
- GSBC $68.02
- SIGA $7.51
- Average True Range (ATR)
- GSBC 1.92
- SIGA 0.36
- MACD
- GSBC 0.74
- SIGA 0.13
- Stochastic Oscillator
- GSBC 64.87
- SIGA 76.87
About GSBC Great Southern Bancorp Inc.
Great Southern Bancorp Inc is a bank holding company. It is principally engaged in the business of originating residential and commercial real estate loans, construction loans, commercial business loans, and consumer loans. The bank provides various services such as Business Banking, Merchant Services, Debit and Credit cards, Online Banking, Mobile Banking, VIP Banking, Overdraft Protection, and various other related services.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.